Zim Removed From TB high Burden Countries List

THE World Health Organisation (WHO), has  removed Zimbabwe from the list of Tuberculosis (TB) high burden countries in its recent global updated list of high burden countries. By Patricia Mashiri The new lists are for 2021–2025 and replace those previously used between 2016 and 2020. Zimbabwe together with other high TB burden countries such as Cambodia, the Russian Federation transitioned  out of the list. Speaking to HealthTimes, Dr Charles Sandy, the Deputy Director, TB and HIV Services  in the Ministry of Health and Child Care (MoHCC) said there was some…

Read More

Take Prescribed TB Drugs Until End Of Course To Avoid Drug Resistance Retail Pharmacists Warn

 ZIMBABWE’S Retail Pharmacists Association (RPA) have raised concern over the growing cases of Drug Resistant Tuberculosis (DR TB) amidst indications that not less that 465 000 people fell ill with multiple-drug resistant TB in 2019. By Staff Reporter In a statement, Jocelyn Chaibva, the Chairperson, Retail Pharmacists Association said there was need to reach out to everyone and ensure no one is left behind. As community pharmacists, we are fully aware and appreciate that: The clock is ticking, hence our joining hands with the rest of the healthcare team on…

Read More

1.4 Million People Missed TB Treatment And Care In 2020 Due To COVID-19

AN estimated 1.4 million fewer people received care for tuberculosis (TB) in 2020 than in 2019, according to preliminary data compiled by the World Health Organization (WHO) from over 80 countries- a reduction of 21% from 2019. . HealthTimes Reporter The countries with the biggest relative gaps were Indonesia (42%), South Africa (41%), Philippines (37%) and India (25%) The effects of COVID-19 go far beyond the death and disease caused by the virus itself. The disruption to essential services for people with TB is just one tragic example of the…

Read More

Why so many people still die from Aids-related illnesses despite more people being on treatment

Twenty years ago antiretroviral medicines for HIV were a rare luxury in South Africa. Exorbitant costs and president Thabo Mbeki’s government fierce government opposition against providing antiretroviral treatment (ART) kept it out of the public sector. Those were terrible days. Many lives were lost. By Dr Gilles Van Cutsem Today, one of the main challenges in the fight against Aids is the lack of availability of diagnostics and drugs that can help save lives of people suffering from advanced HIV; who are very vulnerable to deadly opportunistic infections such as…

Read More